Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2021-09-30
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
NCT04976530
Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban
NCT02403596
Study to Compare the Addition of Floseal to Our Standard of Care to Control Post Operative Bleeding in TKR
NCT01891461
Management of Anticoagulants and Antithrombotics in Patients With CSDH
NCT05079295
Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
NCT04731558
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CytoSorb
Sorbent hemoperfusion system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent for prospective registry participation
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CytoSorbents, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Schmoeckel, Prof, MD
Role: PRINCIPAL_INVESTIGATOR
LMU Klinikum Großhadern
Robert Storey, Prof, BSc
Role: PRINCIPAL_INVESTIGATOR
University of Sheffield
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Graz
Graz, , Austria
Medizinische Universität Innsbruck
Innsbruck, , Austria
Klinikum Klagenfurt am Wörthersee
Klagenfurt, , Austria
Medical University of Vienna
Vienna, , Austria
Centre Hospitalier Universitaire de Liège
Liège, Belgium, Belgium
OLV ziekenhuis Aalst VZW
Aalst, , Belgium
Cliniques Universitaires Saint-Luc
Brussels, , Belgium
University Hospital Ghent
Ghent, , Belgium
Evangelisches Herzzentrum Coswig
Coswig, , Germany
Herzchirurgische Klinik Erlangen
Erlangen, , Germany
Universitätsklinikum Essen
Essen, , Germany
Asklepios Kliniken Hamburg GmbH
Hamburg, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
Universitätsklinikum Heidelberg - Klinik für Herzchirurgie
Heidelberg, , Germany
Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Herz- und Gefäßchirurgie
Kiel, , Germany
Herzzentrum Leipzig and Helios Health Institute GmbH Leipzig
Leipzig, , Germany
Artemed Klinikum München Süd GmbH & Co. KG
Munich, , Germany
LMU Klinikum Großhadern
Munich, , Germany
Deutsches Herzzentrum München
München, , Germany
Klinikum Nürnberg
Nuremberg, , Germany
Klinikum Oldenburg AöR
Oldenburg, , Germany
Krankenhaus der Barmherzigen Brüder Trier
Trier, , Germany
Universitätsklinikum Ulm
Ulm, , Germany
Skåne University Hospital Lund
Lund, , Sweden
Hôpitaux Universitaires Genève
Geneva, , Switzerland
Stadtspital Zürich Clinic for Cardiac Surgery
Zurich, , Switzerland
Universitätsspital Zürich
Zurich, , Switzerland
Blackpool Teaching Hospitals NHS Foundation Trust/ Blackpool Victoria Hospital
Blackpool, , United Kingdom
Royal Brompton & Harefield Clinical Group (part of Guy's and St Thomas' NHS Foundation TRUST)
London, , United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Schmoeckel M, Thielmann M, Hassan K, Geidel S, Schmitto J, Meyer AL, Vitanova K, Liebold A, Marczin N, Bernardi MH, Tandler R, Lindstedt S, Matejic-Spasic M, Wendt D, Deliargyris EN, Storey RF. Intraoperative haemoadsorption for antithrombotic drug removal during cardiac surgery: initial report of the international safe and timely antithrombotic removal (STAR) registry. J Thromb Thrombolysis. 2024 Aug;57(6):888-897. doi: 10.1007/s11239-024-02996-x. Epub 2024 May 6.
Schmitto J, De Somer F, Thielmann M, Marczin N, Ruhparwar A, Meyer AL, Hagl C, Matejic-Spasic M, Wendt D, Fan W, Deliargyris EN, Storey RF, Schmoeckel M. Intraoperative antithrombotic drug removal during heart transplantation: A case series from the International Safe and Timely Antithrombotic Removal (STAR) registry. JHLT Open. 2025 Aug 20;10:100369. doi: 10.1016/j.jhlto.2025.100369. eCollection 2025 Nov.
Storey RF, Hassan K, Meyer AL, Eberle T, deNeve N, Thielmann M, Bernardi MH, Marczin N, Guenther U, Panholzer B, Maechler H, Hunter S, Matejic-Spasic M, Wendt D, Deliargyris EN, Schmoeckel M. Early CABG with intraoperative hemoadsorption in patients on ticagrelor: Real world data from the international Safe and Timely Antithrombotic Removal (STAR) registry. Cardiovasc Revasc Med. 2025 Feb 28:S1553-8389(25)00065-X. doi: 10.1016/j.carrev.2025.02.015. Online ahead of print.
Schmoeckel M, Thielmann M, Vitanova K, Eberle T, Marczin N, Hassan K, Liebold A, Lindstedt S, Machler G, Matejic-Spasic M, Wendt D, Deliargyris EN, Storey RF. Direct-acting oral anticoagulant removal by intraoperative hemoadsorption in CABG and/or single valve surgery: interim analysis of the International Safe and Timely Antithrombotic Removal (STAR) registry. J Cardiothorac Surg. 2025 Jan 20;20(1):74. doi: 10.1186/s13019-024-03326-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
O05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.